Vasculitis related genes cause inflammation of blood vessels

(Medical Xpress) -- Medical Scientists at Trinity College Dublin in a pan-European collaborative study have discovered genes that contribute to the condition vasculitis, causing the inflammation of blood vessels. The findings have been recently published in the leading international publication The New England Journal of Medicine.

Vasculitis can affect all sizes of , including tiny vessels only visible with the aid of a . When a blood vessel becomes inflamed, damage to the tissue to which it supplies ensues.  These conditions may be difficult to diagnose and the events that lead to vasculitis are poorly understood. Genetic factors are known to be involved and details of these genes were revealed in the international study to which the School of Medicine’s Department of Immunology was a contributing centre.  

The study focused on one type of vasculitis called ‘granulomatosis with polyangiitis’ (GPA), an auto-immune disease where cells and other components of the immune system are responsible for the inflammation. GPA is potentially a life threatening condition and its diagnosis has been revolutionised by the development of an antibody test, called the C-ANCA antibody.  This test was introduced in Trinity’s Department of Immunology 15 years ago through which it was  established that this condition was much more common than previously known. More than 250 patients with samples analysed in the Department of Immunology laboratory have been diagnosed over this 15 year time period.  

Through the use of the C-ANCA test, GPA can be diagnosed very specifically and this is a critical detail in entering patients for genetic screening studies.  In this recent study, a powerful method of identifying these examining single nucleotide polymorphisms, was applied to a large group of patients with GPA.  In the first part of the study, 1,223 patients from the UK were investigated and the findings were then confirmed and replicated in 1,454 Northern European patients, including a cohort from  Department of Immunology in St James’s Hospital.  The patients with the C-ANCA antibody possessed a distinct immune-related gene profile which differentiated them from GPA patients with a separate type of auto-antibody, referred to as P-ANCA. 

Commenting on these findings, Professor Conleth Feighery, Emeritus Professor of Immunology and Consultant Immunologist at St James’s Hospital says: “These results not only identify key genetic factors contributing to this inflammatory disease but this in turn could lead to more specific therapies targeting components of the immune system.”

The recently appointed Professor of Nephrology in TCD, Professor Mark Little was also a co-author of this study and has been awarded a research grant to focus on disease mechanisms involved in GPA.  

The lead author of the study was Professor Kenneth GC Smith at the Cambridge Institute for Medical Research at Addenbrooke's Hospital. Other prominent centres included the University of Birmingham, the University of Groningen and Maastricht University  and the Karolinska University Hospital in Sweden and many more.

Related Stories

ANCA-associated vasculitis has genetic component

date Jul 19, 2012

(HealthDay) -- A genome-wide association study of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis shows a genetic contribution to disease susceptibility, which differs between granulomatosis ...

Why some kidney disease patients can't repair blood vessels

date Oct 27, 2011

In some kidney diseases, patients have high blood levels of a protein that blocks blood vessel repair, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). Inhibiting th ...

Long-term rituximab safe for patients with wegener's

date Jul 02, 2012

(HealthDay) -- Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis (GPA; ...

Recommended for you

Protein linked to development of asthma

date Feb 20, 2015

Researchers at the Medical College of Wisconsin (MCW) have linked a specific protein to the development of post-viral infection asthma, which is the first step in generating a novel type of asthma therapy designed to prevent ...

Researchers offer new target for treating asthma

date Feb 18, 2015

Researchers have found a potential new target for treating asthma, according to a study led by researchers at the University of Colorado School of Medicine at the Anschutz Medical Campus and published in the journal Nature Co ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.